PulmoSmart Prime
The same guideline-complete 11-gene NSCLC panel — from a single FFPE sample — delivered in 2 days. For when treatment can't wait, and the oncologist needs the molecular answer before the next clinic visit.
11 genes. 114 variants. One test.
Identical panel to standard PulmoSmart — 99% of DNA mutations and >97% of gene fusions listed in NCCN guidelines (COSMIC v100). Same test, faster path: results in 2 days from a single FFPE block.
What's covered.
Every actionable NSCLC driver an Indian oncologist needs to make a first-line therapy decision — DNA and RNA, in a single sample.
- EGFR · exon 18/19/20/21 (T790M, C797S, L858R)
- ALK · ROS1 · RET · NTRK1/2/3 — RNA fusions
- BRAF V600E · KRAS G12C · MET exon 14
- ERBB2 (HER2) · PIK3CA
- PD-L1 — companion testing
Specifications.
- Platform
- QuantStudio™ 5 real-time PCR
- Indication
- Stage IB–IV NSCLC — fast-track patients
- Sample
- FFPE tissue block or unstained slides
- Turnaround
- 2 days from receipt
- Coverage
- 11 genes · 114 variants · DNA + RNA
- LoD₉₅
- <3% VAF (DNA) · <100 copies (fusions)
- Specificity
- 100%
- Report
- Clinician-ready, priority delivery
For the patients who can't afford a two-week wait.
Fast-progressing disease. Fragile patients where empirical chemotherapy would be brutal. Cases where the oncologist wants the driver identified before the next clinic visit. PulmoSmart Prime is the same molecular answer as standard PulmoSmart — just delivered on a fast-track workflow.
Order PulmoSmart Prime.
Fast-track processing available with prior scheduling. Contact our team to arrange logistics for your first case.
Contact ONCO X Compare all 3 tests